- Home
- /
- About TargetCancer Foundation
- /
- News & Updates
News & Updates
News from TCF
Introducing TCF’s 2025 Boston Marathon team!
As we enter the season of thankfulness and giving, it is with gratitude and excitement that we introduce the 12 incredible individuals who have been selected from the most competitive applicant pool we have ever received to Team TargetCancer Foundation 2025! We are...
Patients and Practitioners as Partners: 2024 Rare Cancer Day Webinar
On September 30, TargetCancer Foundation was pleased to host a Lunch and Learn Webinar in honor of Rare Cancer Day. Dr. Mina Nikanjam, an oncologist at University of California San Diego Health, and Dana Deighton, a rare cancer patient advocate and Director of...
Making Rare Cancer Day A Reality
This reflection was written by: Jim Palma, Chief Executive Officer Like many people in the rare cancer advocacy world, I entered my own advocacy work unexpectedly, and through the experience of a family member. In my case, it was through my brother-in-law Paul, who...
Connecting the Dots: Two Months at TCF
This reflection was written by: Hetal Vig, MS, MGC, Director of Research and Clinical Engagement In the words of Steve Jobs, “You can’t connect the dots looking forward; you can only connect them looking backwards. So you have to trust that the dots will somehow...
TCF In the News
Molecular Tumor Boards Improve Precision Medicine Access, but Increasing Patient Reach a Challenge
Rare Cancers - Limited Treatments, Limited Research, Tons of Advocacy
TCF-001 TRACK : A Clinical Trial Studying Precision Medicine in Rare Cancers
Kelly, House Cancer Caucus co-chairs introduce resolution to recognize September 30 as 'Rare Cancer Day'
Creating a Public-Private Partnership to Support Development of Anti-Cancer Therapies for Ultra-Rare Tumor Indications
Leveraging Technology to Streamline Biomarker Testing
Luminary Awards Honor GI Experts, Patient Advocate
Target Cancer Foundation Gala returns to raise money for fight against rare cancers
Local foundation building hope for families facing rare cancer diagnosis
Treating Rare Cancers Can Be Hard: Why Genomic Testing Is Crucial - Conquer: the journey informed
TargetCancer Foundation Enrolls First Patient to Decentralized, Rare Cancer TRACK Study
Grief and Survival Sit Side by Side
Research Advocates, Leading Docs to Expand Precision Medicine Access With Decentralized Model
Foundation Medicine, TargetCancer Foundation to test 'precision medicine'
TargetCancer Foundation Announces Rare Cancer Precision Medicine Research Initiative
TargetCancer Foundation Initiates Precision Medicine Study for Rare Cancers
Rare Cancers are Common, So Why the Lack of Research Funding?
Mark Your Calendars- October 1 is Rare Cancer Day
Funding a Hopeful Future for Rare Cancer Research
Over coffee, a research collaboration is born
Dancing to Live
Targeting Rare Cancers for Research and Treatment
Cancer Benefit Targets Hope and Healing
Dean & Britta to play TargetCancer benefit
News in Brief: TargetCancer, ATP, Parenthetical Girls, and Unthanks
Media Contact
Kristen Palma
President
kristen@targetcancerfoundation.org
617.765.4881